Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1017459)
Text and Data Mining valid from 2018-05-21
Received: 4 August 2017
Accepted: 9 April 2018
First Online: 21 May 2018
: SEM is a clinician and research associate at University College London (UCL). FC is a radiology consultant at Barts Health trust, NHS, UK. AC is a Medical Research Council (MRC) senior statistician. RD is an associate professor at University of Cape Town Lung Institute. MM is a clinician and research associate at UCL. SRM is Senior Medical Officer at TB Alliance. AJN is Associate Director and Chair of Infection Research at MRC. PPJP is a senior statistician at MRC. CM is Senior VP of Research and Development at TB Alliance. KPS is a clinician and research associate at UCL. TDM is Professor of Clinical Microbiology at UCL and Director of the UCL Centre for Clinical Microbiology. SHG is the Sir James Black Professor of Medicine at the University of St Andrews.
: The UCL ethics committee and the ethics committees of all study sites and organizations approved the REMoxTB study; these are provided in Additional file InternalRef removed. Patients gave their informed consent for the REMoxTB study and for their specimens and data to be used for the purposes of this study [CitationRef removed].
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.